Cite
HARVARD Citation
Cho, B. et al. (2021). Anti–cytotoxic T-lymphocyte–associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer. Lung cancer. pp. 162-170. [Online].